不同含量的锌对糖尿病肾病的作用及相关机制研究
本文选题:锌 + 糖尿病肾病 ; 参考:《吉林大学》2015年博士论文
【摘要】:糖尿病(diabetes mellitus,DM)是由葡萄糖产生和代谢异常导致内环境紊乱而引发的多因素的慢性代谢障碍性疾病。它的主要特点是由于胰岛的产生、分泌异常或二者皆可和胰岛素抵抗、炎症、氧化应激等造成的血糖和血脂代谢失衡。随着经济的迅猛发展、生活标准的提高、饮食和生活方式的改变和老龄化,糖尿病已经成为世界范围内的重要的公共健康问题,是继恶性肿瘤和心脑血管疾病之后的第三大威胁公共健康的疾病。据统计糖尿病的全球患病人数在2000年已经达到1.51亿人,预计2030年在年龄大于20岁的人群中患病人数将达到5.52亿。糖尿病及其并发症的治疗给个人、家庭及社会都带来了沉重的经济负担,如何预防糖尿病和控制糖尿病并发症的发生发展,已经成为医学界迫于被解决的热点问题。 糖尿病可以影响机体的多种器官系统,,如肾脏系统、神经系统和眼睛等,随着时间的进展都可以导致严重的糖尿病并发症。作为糖尿病微血管疾病之一的糖尿病肾病,不仅是糖尿病最常见的并发症之一,也是糖尿病患者死亡的最主要病因之一。尽管控制血糖、血压、降低脂质水平和抑制肾素血管紧张素系统被用于治疗糖尿病,但糖尿病肾病的发生和发展仍是不可预防的。糖尿病肾病的主要组织学特点是肾小球肥大、肾小球基底膜增厚、细胞外基质增多和最终的肾小球球性硬化。而氧化应激介导糖尿病对肾脏组织功能的不利影响;高血糖诱导的活性氧自由基干扰微血管和促进细胞外基质积聚。所以,如何调节氧化酶活性和提高抗氧化能力被认为是预防和延缓糖尿病肾病的发生和发展的重要手段之一。 锌作为人体的必需微量元素之一,参与多种生理过程。同时,锌是蛋白的必要组成部分,主要参与维持细胞结构和细胞膜的稳定性。锌的功能包括可以维持人类基因组中2000多种锌依赖的转录因子的细胞结构稳定,并且对超过300多种锌金属酶的生物活性起着关键作用。 在糖尿病状态下,常伴有锌缺乏。除了饮食过程中锌摄入不足,糖尿病患者吸收和/或重吸收锌受损和尿锌排泄增加,都可以增加内源性锌的丢失。锌不仅在胰岛素作用和碳水化合物代谢中起着重要的作用,而且在机体的抗氧化机制中也有着不可或缺的作用。目前,氧化应激已经被认为在糖尿病及其并发症的发病机制中至关重要。锌是超氧化物歧化酶等关键的抗氧化酶的重要组成部分,锌缺乏导致抗氧化酶的抗氧化能力下降,从而导致机体内氧化应激增加。但是不同含量的锌对糖尿病肾病的作用及其可能的具体机制尚不明确,为此我们进行了以下研究。 我们给予8周龄的FVB雄性小鼠小剂量STZ(50mg/kg)连续腹腔注射5天,1周后通过小鼠尾静脉检测血糖,以血糖水平大于16.7mmol/L定为成功建立1型糖尿病动物模型。成模后,我们给予美国Research Diets公司的商品化不同含量锌的成品饲料饲养糖尿病和对照组小鼠3个月,通过体内锌含量检测证实成功建立不同锌含量的1型糖尿病动物模型。然后,我们通过Western blot,病理组织学检查等实验方法检测肾功能、肾脏病理改变、氧化损伤、炎症损伤和纤维化损伤,探讨不同含量的锌饲养对糖尿病小鼠诱导肾脏损伤的作用。随后,我们通过检测Nrf2及其下游抗氧化因子的表达水平,探讨不同含量的锌对糖尿病诱导肾脏损伤作用的可能机制。最后,我们检测AKT、GSK-3β及Fyn水平,进一步探讨锌对AKT及其下游相关代谢信号的激活作用,从而探讨锌、AKT和Nrf2之间可能的关系。结果如下: 1.不同含量的锌饲养糖尿病小鼠3个月,糖尿病各组小鼠间的血糖、体重和肾重/体重比值水平差异无显著性改变。 2.在糖尿病各组中,低锌干预的糖尿病组小鼠的死亡率、ACR值和尿素氮值显著升高;正常锌和高锌干预可以改善上述症状,尤其是高锌干预。 3.与其相应对照组比较,糖尿病组中肾脏氧化损伤指标SOD1和SOD2的表达下降,炎症指标PAI-1和TNF-α、纤维化指标CTGF和TGF-β1的表达增加;在糖尿病各组中,低锌干预可以使上述损伤进一步加重,而正常锌和高锌干预后,尤其是高锌干预,可以改善上述肾脏损伤。 4.通过PAS染色发现与其相应对照组比较,糖尿病组出现肾小球肥大、细胞外基质增多和肾小管间质损伤;通过透射电镜检查发现与其相应对照组比较,糖尿病组表现为肾小球基底膜增厚、上皮足突节段融合和肾小管上皮细胞中线粒体肿胀;低锌干预有进一步加重上述损伤的趋势,而正常锌和高锌干预可以部分改善肾脏的病理损伤。 5.与其相应对照组比较,糖尿病组肾脏中Nrf2及其下游抗氧化因子的表达下降;在糖尿病各组中,低锌干预可以使其表达进一步下降,而正常锌和高锌干预,可以诱导Nrf2及其下游抗氧化因子的表达上调,尤其是高锌干预。 6.与其相应对照组比较,糖尿病组肾脏中AKT和GSK-3β的磷酸化水平下降;在糖尿病各组中,低锌干预可以使其磷酸化水平进一步下降,而正常锌和高锌干预,可以调节AKT和GSK-3β的磷酸化水平升高,尤其是高锌干预。 7.与其相应对照组比较,糖尿病组肾脏中Fyn核转位增加,导致Nrf2从核内转出增加,最终Nrf2降解增加;在糖尿病各组中,低锌干预可以使Fyn核转位进一步增加,而正常锌和高锌干预,Fyn核转位减少,从而上调Nrf2的表达,尤其是高锌干预。 通过以上实验结果,我们得出结论:低锌干预一定程度上加重了糖尿病诱导的肾脏损伤;而给予正常锌和高锌干预可以对糖尿病诱导肾脏损伤起到部分的保护作用,尤其是高锌干预;这种保护作用部分是通过诱导Nrf2的表达和功能而实现的。而可能的调节机制之一是锌部分通过活化AKT降低GSK-3β的活性来抑制Fyn核转位,从而导致Nrf2在细胞核内积聚而增加其下游抗氧化因子NQO1、SOD等的表达部分实现其抗氧化损伤的作用,最终对糖尿病诱导肾脏损伤起到一定程度的保护作用。
[Abstract]:Diabetes mellitus (DM) is a multi factor chronic metabolic disorder caused by the disturbance of glucose production and metabolism, which is mainly characterized by the production of islets, abnormal secretion of insulin, and the imbalance of blood glucose and lipid metabolism caused by insulin resistance, inflammation, oxidative stress and so on. With the rapid development of economy, the improvement of standard of living, the change of diet and lifestyle and aging, diabetes has become an important public health problem in the world. It is the third major threat to public health after malignant tumor and cardiovascular disease. According to statistics, the number of diabetic global diseases has reached 1. in 2000. 5 billion 100 million people are expected to reach 552 million in the population older than 20 years of age in 2030. The treatment of diabetes and its complications has brought a heavy economic burden to individuals, families and society. How to prevent diabetes and control the development of diabetes complications has become a hot issue in the medical field.
Diabetes can affect a variety of organ systems, such as the kidney system, the nervous system, and the eyes, which can lead to serious diabetic complications as time progresses. As one of the diabetic microvascular diseases, diabetic nephropathy is not only one of the most common complications of diabetes, but also the most important disease of diabetic patients. One of the reasons. Although controlling blood sugar, blood pressure, lowering lipid levels and inhibiting the renin angiotensin system are used in the treatment of diabetes, the occurrence and development of diabetic nephropathy are still not preventable. The main histologic features of diabetic nephropathy are glomerular hypertrophy, thickening of the glomerular basement membrane, increased extracellular matrix and final glomeruli. And oxidative stress mediates the adverse effects of diabetes on the function of the kidneys; hyperglycemia induced reactive oxygen free radicals interferes with microvessels and promotes the accumulation of extracellular matrix. Therefore, how to regulate oxidase activity and increase antioxidant capacity is considered as an important means to prevent and delay the occurrence and development of hyperglycuria nephropathy One of.
Zinc is one of the essential trace elements of the human body and participates in a variety of physiological processes. At the same time, zinc is a necessary component of the protein. It is mainly involved in maintaining the stability of the cell structure and cell membrane. The function of zinc includes the stability of the cell structure of more than 2000 zinc dependent transcription factors in the human genome, and more than 300 kinds of zinc gold. The biological activity of the enzyme plays a key role.
In diabetes, zinc deficiency is often accompanied by deficiency of zinc. In addition to insufficient zinc intake during diet, the loss of endogenous zinc can be increased in diabetic patients with impaired absorption and / or reabsorption of zinc and increased urine zinc excretion. Zinc not only plays an important role in insulin and carbohydrate metabolism, but also in the body's antioxidant mechanism. At present, oxidative stress has been considered important in the pathogenesis of diabetes and its complications. Zinc is an important component of the key antioxidant enzymes such as superoxide dismutase. Zinc deficiency leads to the decline in antioxidant capacity of antioxidant enzymes, resulting in increased oxidative stress in the body. The role of zinc in diabetic nephropathy and its possible mechanism are not clear.
We gave 8 weeks old FVB male mice with small dose STZ (50mg/kg) for 5 days of continuous intraperitoneal injection. After 1 weeks, the blood glucose was detected by the tail vein of mice. The model of type 1 diabetes mellitus was established successfully with the blood glucose level greater than 16.7mmol/L. After 3 months of disease and control mice, the zinc content of type 1 diabetic animal models with different zinc content was successfully established. Then, we examined renal function, pathological changes of kidney, oxidative damage, inflammatory injury and fibrosis by Western blot and histopathological examination. The effect of diabetic mice induced renal injury. Then, by detecting the expression level of Nrf2 and its downstream antioxidant factors, we explored the possible mechanism of different levels of zinc on diabetic induced renal injury. Finally, we detected the levels of AKT, GSK-3 beta and Fyn, and further explored the activation of zinc on AKT and its downstream related metabolic signals. To explore the possible relationship between zinc, AKT and Nrf2. The results are as follows:
1. there was no significant difference in blood sugar, body weight and kidney weight / body weight ratio among diabetic mice in different concentrations of zinc for 3 months.
2. in the diabetic group, the mortality, ACR and urea nitrogen in the low zinc intervention diabetic group increased significantly, and the intervention of normal zinc and high zinc could improve the above symptoms, especially the high zinc intervention.
3. compared with the corresponding control group, the expression of renal oxidative damage index SOD1 and SOD2 decreased in the diabetic group, the expression of inflammatory markers PAI-1 and TNF- a, the expression of CTGF and TGF- beta 1 in the fibrosis index increased. In the diabetic group, the low zinc intervention could further aggravate the above damage, and the prognosis of normal zinc and high zinc, especially the high zinc intervention, could be used in diabetic group. To improve the injury of the kidneys.
4. compared with the corresponding control group, the diabetic group showed the glomerular hypertrophy, the increase of extracellular matrix and the renal tubulointerstitial damage in the diabetic group. Through the transmission electron microscopy, the diabetic group showed the thickening of the glomerular basement membrane, the fusion of the epithelial podocyte segment and the mitochondria in the renal tubular epithelial cells compared with the corresponding control group. Swelling, low zinc intervention further aggravated the above damage trend, while normal zinc and high zinc intervention can partially improve the pathological damage of kidney.
5. compared with the corresponding control group, the expression of Nrf2 and its downstream antioxidant factors in the kidneys of the diabetic group decreased, and the low zinc intervention could further decrease the expression in the diabetic group, while the intervention of normal zinc and high zinc could induce the up regulation of Nrf2 and its downstream antioxidant factors, especially the high zinc intervention.
6. compared with the corresponding control group, the level of phosphorylation of AKT and GSK-3 beta in the kidneys of the diabetic group decreased, and the low zinc intervention could further decrease the phosphorylation level in the diabetic group, while the normal zinc and the high zinc intervention could regulate the increase of the phosphorylation level of AKT and GSK-3 beta, especially the high zinc intervention.
7. compared with the corresponding control group, the Fyn nucleus transposition in the kidneys of the diabetic group increased, resulting in the increase of Nrf2 from the nucleus and the increase of Nrf2 degradation. In all diabetic groups, the low zinc intervention could further increase the transposition of the Fyn nucleus, while the normal zinc and high zinc intervention, the Fyn nuclear transposition decreased, so that the expression of Nrf2 was up-regulated, especially the high zinc intervention.
Through the experimental results, we conclude that low zinc intervention aggravates the renal injury induced by diabetes to some extent, and that the intervention of normal zinc and high zinc can partly protect the kidney injury induced by diabetes, especially the high zinc intervention; this protection is partly by inducing the expression and function of Nrf2. One of the possible regulatory mechanisms is that one of the possible mechanisms of regulation is that the zinc part reduces the GSK-3 beta activity by activating AKT to inhibit the transposition of the Fyn nucleus, resulting in the accumulation of Nrf2 in the nucleus and increasing its downstream antioxidant factor NQO1, SOD and other expressions to achieve its antioxidant damage, which ultimately induces a certain degree of renal injury induced by diabetes. The protective effect.
【学位授予单位】:吉林大学
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R587.2
【相似文献】
相关期刊论文 前10条
1 黄列军,曹莜芬;糖尿病的主要危害是什么?[J];中国临床医生;2001年01期
2 梅晰凡,王伟;糖尿病足40例疗效观察[J];中国煤炭工业医学杂志;2001年04期
3 胡怀东,王玉君,庞久高;2型糖尿病患者尿Ⅳ型胶原与糖尿病肾病关系的研究[J];重庆医科大学学报;2001年01期
4 卢盛明,戴林,李爱萍;1例糖尿病并发严重多脏器功能障碍综合征患者治愈分析[J];中国危重病急救医学;2001年09期
5 姜醒,苑光军,马丽红;糖尿病的中医药治疗近况[J];中医药信息;2001年05期
6 孙德胜,肖萤;超声评价糖尿病肾病[J];中国医学影像技术;2001年01期
7 马为,郭泉滢,唐桂军;以糖肾安为主配合西药治疗糖尿病肾病60例[J];中医研究;2001年04期
8 翁小刚;中药治疗3例糖尿病肾病[J];国外医学(中医中药分册);2001年06期
9 周逸丹;;糖尿病饮食治疗现状[J];国外医学(老年医学分册);2001年02期
10 滕万同,杨莉;糖尿病性腹泻42例治疗体会[J];山东医药;2002年16期
相关会议论文 前10条
1 沙洪;肖诚;赵婷婷;郭景珍;黄小洁;王萍;李平;;糖尿病肾病的健康教育[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年
2 杨丽平;李平;;糖尿病肾病合并贫血的相关发病机制[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年
3 周海鸥;王黎芳;杨佳琦;钱大昕;陈士华;;社区糖尿病病人现状分析与对策[A];浙江省医学会医学微生物与免疫学及医学病毒学学术年会论文汇编[C];2009年
4 葛菲菲;;糖尿病肾病早期诊疗进展[A];第10届全国中西医结合肾脏病学术会议论文汇编[C];2009年
5 李桂芝;于道兰;;糖尿病肾病的饮食调理[A];中华护理学会全国第6届重症监护护理学术交流暨专题讲座会议论文汇编[C];2009年
6 金砾;;浅谈糖尿病的护理[A];第十四次全国中西医结合疡科学术交流会论文汇编[C];2009年
7 奚九一;;糖尿病足有二种坏死很难分辨,奚氏中医辨证可区别[A];中华中医药学会周围血管病分会2010年学术大会论文集[C];2010年
8 高继宁;赵怡蕊;李跃进;;糖尿病肾病的中西医结合治疗新进展[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年
9 芦文娟;方敬爱;孙艳艳;张晓东;刘文媛;常沁涛;王蕊花;王月香;李慧;刘婷;;抗坏血酸与糖尿病肾病[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年
10 简桂花;盛晓华;汪年松;;中西医结合治疗糖尿病肾病疗效观察[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年
相关重要报纸文章 前10条
1 马明愈;现代生活方式导致 糖尿病发病率迅速上升[N];中国妇女报;2005年
2 主持人 向红丁博士;糖尿病肾病须早防早治[N];人民政协报;2002年
3 华悦;预防糖尿病,从减肥开始[N];上海中医药报;2004年
4 刘冬梅;肥胖糖尿病第一诱因[N];天津日报;2004年
5 李学燕;中药辅助治糖尿病肾病[N];健康时报;2007年
6 李旭红;中医帮您远离糖尿病[N];市场报;2007年
7 吕洋;糖尿病患者警惕血管病变[N];卫生与生活报;2007年
8 记者 崔昕;中药早期防治糖尿病肾病取得突破性进展[N];中国医药报;2006年
9 崔昕;《糖尿病中医防治指南》发布[N];中国医药报;2007年
10 记者 周颖邋高新军;防治糖尿病首部中医指南发布[N];中国中医药报;2007年
相关博士学位论文 前10条
1 尹士男;40岁以下发病2型糖尿病患者的临床和分子遗传学特点初步分析[D];中国人民解放军军医进修学院;2002年
2 职心乐;天津市2型糖尿病及其并发症患病率调查及相关危险因素研究[D];天津医科大学;2007年
3 付文金;尿液组织因子促凝活性检测方法的建立及其在糖尿病肾病中的应用研究[D];南方医科大学;2011年
4 孙晓泽;中医辨证治疗早期和临床期糖尿病肾病的临床研究[D];广州中医药大学;2011年
5 苑迅;糖肾康治疗糖尿病肾病机理研究[D];黑龙江中医药大学;2002年
6 李伟华;澳门与广州地区2型糖尿病中医证型特点比较与探讨[D];广州中医药大学;2012年
7 王俊杰;香港地区2型糖尿病的中医证型特点[D];广州中医药大学;2012年
8 徐亚兰;2型糖尿病肾脏损害与糖尿病视网膜病变相关性的临床和病理研究[D];中国协和医科大学;2008年
9 丁丹;胃肠外科手术治疗糖尿病血清蛋白质组学研究[D];第二军医大学;2011年
10 郭茂田;中西医结合诊治糖尿病的现状及发展前景[D];南京中医药大学;2004年
相关硕士学位论文 前10条
1 张双;糖尿病伴发贫血的影响因素分析[D];浙江大学;2009年
2 李燕玲;双重糖尿病临床特征的探讨[D];中南大学;2009年
3 孙永胜;2型糖尿病肾病临床调查分析[D];遵义医学院;2009年
4 吴楠;2型糖尿病住院患者慢性肾脏病诊断方法初探[D];复旦大学;2010年
5 苏丽丽;尿液的表面增强拉曼光谱检测用于糖尿病的研究[D];大连理工大学;2011年
6 肖憬;2型糖尿病肾病患者白介素-8、白介素-10的变化及临床意义[D];兰州大学;2011年
7 黎雅清;2型糖尿病患者心率变异度与糖尿病肾病的关系[D];暨南大学;2005年
8 卜彦屏;糖尿病足危险因素探讨[D];天津医科大学;2002年
9 陈宽林;血清转化生长因子β_1与2型糖尿病肾病相关性临床研究[D];福建医科大学;2002年
10 马文革;社区2型糖尿病患者治疗行为调查及健康教育干预效果研究[D];安徽医科大学;2004年
本文编号:1995449
本文链接:https://www.wllwen.com/yixuelunwen/nfm/1995449.html